Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Sarah Whitney | F | 60 |
University College London
| - |
Mark P. Richmond | M | 92 |
University College London
| - |
Katharine Roseveare | F | - |
University College London
| - |
Michael Underwood | M | - |
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | 10 ans |
Shervanthi Homer-Vanniasinkam | M | 65 |
University College London
| - |
Amit Chunilal Nathwani | M | 64 |
University College London
| 13 ans |
Sergio Quezada | M | 49 |
University College London
| 13 ans |
Josephine Clare Baroness Valentine | F | 66 |
University College London
| - |
Mark Lowdell | M | 61 |
University College London
| 30 ans |
Mariana Mazzucato | M | 56 |
University College London
| 7 ans |
Julia Prescot | F | 65 |
University College London
| - |
Christopher Mason | M | 66 |
University College London
| 25 ans |
Saladin Meckled-Garcia | M | - |
University College London
| - |
Ven Balakrishnan | M | - |
University College London
| - |
Maria Wyke | F | - |
University College London
| - |
David Attwell | M | - |
University College London
| - |
Kai Kit Wong | M | 50 |
University College London
| 9 ans |
Stephanie Schorge | M | - |
University College London
| - |
Nick McGhee | M | - |
University College London
| - |
Mark Sudbury | M | - |
University College London
| - |
Clare Goudy | F | - |
University College London
| - |
Nigel Waugh | M | - |
University College London
| - |
Paul Ayris | M | - |
University College London
| - |
Peter Cadley | M | - |
University College London
| - |
Wendy Appleby | F | - |
University College London
| - |
Magnus Nyden | M | - |
University College London
| - |
Mark Miodownik | M | - |
University College London
| - |
Claire Callender | F | - |
University College London
| - |
Ian Dato | M | 46 |
University College London
| - |
Dame Angela Strank | M | 71 |
University College London
| - |
DeAnne Shirley Julius | M | 75 |
University College London
| 10 ans |
David Knox | M | 66 |
University College London
| - |
Mark Emberton | M | - |
University College London
| - |
Brenda Reynolds | M | - |
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | - |
Vanessa Lawrence | M | - |
University College London
| - |
Roy Quilliam | M | 63 |
University College London
| - |
José-Alain Sahel | M | 68 |
University College London
| - |
Michael Pepper | M | - |
University College London
| 15 ans |
Peter Parker | M | - |
University College London
| - |
Stanton Peter Newman | M | 75 |
University College London
| - |
David Campbell | M | 80 |
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | 19 ans |
John Reid | M | 77 |
University College London
| - |
John Marshall | M | 80 |
University College London
| - |
Adele Biss | F | - |
University College London
| - |
Junaid Bajwa | M | 45 |
University College London
| - |
Derek Lionel Glendon Hill | M | 58 |
University College London
| 29 ans |
John Collinge | M | 66 |
University College London
| - |
Ted Dinan | M | - |
University College London
| - |
John W. Martin | M | - |
University College London
| - |
John Tite | M | - |
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | 15 ans |
Matt Harvey | M | - |
University College London
| - |
David Delpy | M | - |
University College London
| 25 ans |
Quentin Pankhurst | M | - |
University College London
| - |
Michael Arthur | M | - |
University College London
| 11 ans |
Derralynn Hughes | F | - |
University College London
| - |
Dominic Blakemore | M | 54 |
University College London
| - |
Chris Russell | M | - |
University College London
| - |
Melissa Terras | F | - |
University College London
| - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Jack Boyer | M | 65 |
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | - |
Mike Whelan | M | - |
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | - |
Peter Woodford | M | 76 |
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | - |
Brent Bartlett | M | - |
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | - |
Vic Laville | M | - |
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | - |
Statistiques
Pays | Relations | % du total |
---|---|---|
Royaume-Uni | 63 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- William Rosenberg
- Réseau Personnel